Chirag Talati, pharma analyst, Espirito Santo Securities says the RBI's move to boost the Indian currency by asking exporters to convert 50% of their foreign exchange holdings into rupees will not have a significant impact on pharma companies.
first published: May 10, 2012 02:56 pm
A collection of the most-viewed Moneycontrol videos.

Exclusive Post-Budget Interview: FM Sitharaman in Conversation with Rahul Joshi

Live: Nifty moves closer to 25,000 after Budget day selloff | Closing Bell

Markets Beyond The Budget : What Next For Indian Investors ?

Nifty Braces For Further Pain As FIIs Return|Big Market Voices Decode STT Shock | Opening Bell Live
You are already a Moneycontrol Pro user.